{
    "clinical_study": {
        "@rank": "60399", 
        "arm_group": [
            {
                "arm_group_label": "Test Study 1:  2-15N glutamine", 
                "arm_group_type": "Active Comparator", 
                "description": "To determine the contributions make by glutamine to the provision of nitrogen for ornithine, citrulline and arginine syntesis in adults."
            }, 
            {
                "arm_group_label": "Test Study 2: 15N2 arginine &15N proline", 
                "arm_group_type": "Active Comparator", 
                "description": "administration of 15N2 arginine &15N proline to measure arginine and proline flux"
            }, 
            {
                "arm_group_label": "Study Test 3: 1-13C glutamine", 
                "arm_group_type": "Active Comparator", 
                "description": "to determine to contribution of glutamine to the carbon skeleton of ornithine, citrulline and arginine in adults."
            }
        ], 
        "brief_summary": {
            "textblock": "Arginine synthesis in mammals is a complex process involving at least 8 enzymes and\n      intracellular and interorgan transfer of substrates.\n\n      The investigators have shown in our neonatal studies that there is no conversion of\n      glutamate to arginine but proline label appears in ornithine, citrulline and arginine. It is\n      clear therefore that arginine is synthesized in human neonates from proline.\n\n      In adults the source of the carbon backbone is less clear."
        }, 
        "brief_title": "Arginine Synthesis in Healthy Adult Humans", 
        "completion_date": {
            "#text": "June 2008", 
            "@type": "Actual"
        }, 
        "condition": "Healthy", 
        "detailed_description": {
            "textblock": "Through a series of test in healthy adults using tandem mass spectrometry with carbon\n      labeled GLN and nitrogen labeled PRO to determine the dietary source for the carbon chain of\n      ORN, CIT and ARG. Additionally, using Nitrogen labeled GLN, we will identify the source of\n      the nitrogen atoms in these amino acids.\n\n      Using guanidino - 15N2 arginine, 1-13C Glutamine, 2-15N Glutamine and 15N Proline we will be\n      able to:\n\n        1. determine the flux of arginine and proline in healthy adult volunteers\n\n        2. determine and compare the flux of carbon and nitrogen labeled glutamine\n\n        3. demonstrate whether glutamine or proline provides the carbon backbone for ornithine,\n           citrulline and arginine in adults.\n\n        4. the source of the N atoms in ornithine, citrulline and arginine."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  5 men of average weight 80 kg will be studied\n\n          -  healthy, with no know disease of liver, and/or kidney\n\n          -  weight stable\n\n        Exclusion Criteria:\n\n          -  weith loss or gain over the last three months\n\n          -  on medications known to affect amino acid metabolism\n\n          -  known liver, kidney disease condition"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "6", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01912235", 
            "org_study_id": "02/02/2010"
        }, 
        "intervention": [
            {
                "arm_group_label": "Test Study 1:  2-15N glutamine", 
                "description": "Glutamine with N15 isotope tracer", 
                "intervention_name": "2-15N glutamine", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Test Study 2: 15N2 arginine &15N proline", 
                "description": "Arginine and Proline isotope tracers", 
                "intervention_name": "15N2 arginine and 15N proline", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Study Test 3: 1-13C glutamine", 
                "description": "Glutamine carbon isotope tracer", 
                "intervention_name": "1-13C glutamine", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Arginine synthesis", 
            "15N2 arginine, 1-13C Glutamine, 2-15N Glutamine, 15N Proline"
        ], 
        "lastchanged_date": "August 7, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Toronto", 
                    "country": "Canada", 
                    "state": "Ontario"
                }, 
                "name": "The Hospital for Sick Children"
            }
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "3", 
        "official_title": "Arginine Synthesis in Healthy Adult Humans: Does Proline or Glutamate Provide the 5-Carbon Chain?", 
        "overall_official": {
            "affiliation": "The Hospital for Sick Children", 
            "last_name": "Paul Pencharz, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Canada: Research Ethics Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2008", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Blood Isotope Levels", 
            "safety_issue": "No", 
            "time_frame": "8 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01912235"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The Hospital for Sick Children", 
            "investigator_full_name": "Dr. Paul Pencharz", 
            "investigator_title": "Emeritus Scientist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "The Hospital for Sick Children", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "The Hospital for Sick Children", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2007", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}